https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Spinal multiparametric MRI and DEXA changes over time in men with prostate cancer treated with androgen deprivation therapy: a potential imaging biomarker of treatment toxicity https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33054 5 % BMD loss after 1 year had triple the percentage increase in MRS FF at 6 months (61.1 % vs. 20.9 %, p = 0.19). Conclusions: Changes are observed on L-spine MRI after 6 months of ADT. Further investigation is warranted of MRS change as a potential predictive biomarker for later BMD loss.]]> Wed 09 Mar 2022 16:02:16 AEDT ]]> Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51990 Tue 26 Sep 2023 10:53:57 AEST ]]> A multi-center prospective study for implementation of an MRI-only prostate treatment planning workflow https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39881 Tue 04 Oct 2022 15:37:28 AEDT ]]> Phase 2 multicenter study of gantry-based stereotactic radiotherapy boost for intermediate and high risk prostate cancer (PROMETHEUS) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34741 Thu 17 Feb 2022 09:29:26 AEDT ]]> Validity of the common cold questionnaire (CCQ) in asthma exacerbations https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:4455 Sat 24 Mar 2018 10:12:16 AEDT ]]>